VEINOPHAR
Food supplement declared in France, declaration No 2019-7-701, decision dated 11 July 2019
VEINOPHAR is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- PHARMACIE SAINT JOSEPH
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 3 gélules
- Directions for use
- 2 gélules par jour. Jusqu'à 3 gélules en aigu
- Not recommended for (according to the manufacturer)
- Sous anticoagulants
Declaration 296804, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Aesculus hippocastanum L. | Graine | Extrait sec hydroalcoolique | 375 mg |
| Citrus sinensis (L.) Osbeck | Fruit | Extrait sec aqueux | 300 mg |
| Vitis vinifera L. | Feuille | Poudre (de plantes séchées ou broyées) | 300 mg |
| Vitis vinifera L. | Pépin | Extrait sec hydroalcoolique | 150 mg |
Additives
Hydroxypropyl Méthyl Cellulose
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- VEINOPHAR SAS Prophar, declared in 2024, withdrawal announced : different composition: 1 ingredient(s) added, 1 missing
- VEINO-PHAR SAS Prophar, declared in 2024 : different composition: 1 ingredient(s) added, 1 missing
- VEINOPHAR SAS Prophar, declared in 2018, withdrawn from the market : same declared composition